| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 11 | 2024 | 1214 | 1.050 |
Why?
|
| Glioma | 8 | 2024 | 489 | 0.980 |
Why?
|
| Astrocytoma | 1 | 2023 | 99 | 0.820 |
Why?
|
| Muscular Diseases | 2 | 2023 | 104 | 0.540 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2023 | 3570 | 0.490 |
Why?
|
| Astrocytes | 4 | 2019 | 250 | 0.470 |
Why?
|
| Glioblastoma | 4 | 2023 | 330 | 0.460 |
Why?
|
| Brain Stem | 2 | 2021 | 115 | 0.360 |
Why?
|
| Ameloblastoma | 1 | 2010 | 3 | 0.350 |
Why?
|
| Jaw Neoplasms | 1 | 2010 | 4 | 0.350 |
Why?
|
| Ependymoma | 2 | 2022 | 125 | 0.350 |
Why?
|
| Rheumatic Diseases | 1 | 2011 | 69 | 0.340 |
Why?
|
| Thrombocytopenia, Neonatal Alloimmune | 1 | 2010 | 2 | 0.340 |
Why?
|
| NFI Transcription Factors | 3 | 2019 | 50 | 0.330 |
Why?
|
| Oligodendroglia | 3 | 2020 | 76 | 0.320 |
Why?
|
| Rheumatology | 1 | 2011 | 120 | 0.320 |
Why?
|
| Diseases in Twins | 1 | 2010 | 94 | 0.320 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2020 | 36 | 0.310 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2023 | 80 | 0.310 |
Why?
|
| Carcinogenesis | 4 | 2022 | 334 | 0.300 |
Why?
|
| Xanthogranuloma, Juvenile | 2 | 2022 | 31 | 0.300 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2022 | 71 | 0.290 |
Why?
|
| Immunoglobulins | 2 | 2024 | 173 | 0.270 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 948 | 0.260 |
Why?
|
| Calcium-Binding Proteins | 2 | 2005 | 325 | 0.260 |
Why?
|
| Cerebellum | 1 | 2010 | 415 | 0.260 |
Why?
|
| Premature Birth | 1 | 2010 | 384 | 0.250 |
Why?
|
| Teratoma | 2 | 2018 | 120 | 0.240 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 675 | 0.240 |
Why?
|
| Calcinosis | 2 | 2024 | 178 | 0.230 |
Why?
|
| Amphetamine | 1 | 2004 | 13 | 0.230 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2004 | 58 | 0.230 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2005 | 172 | 0.220 |
Why?
|
| Brain | 6 | 2024 | 2999 | 0.220 |
Why?
|
| Neuroglia | 2 | 2017 | 204 | 0.220 |
Why?
|
| Interneurons | 2 | 2005 | 143 | 0.220 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2024 | 32 | 0.220 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 1140 | 0.220 |
Why?
|
| Frontal Lobe | 1 | 2004 | 116 | 0.220 |
Why?
|
| Craniopharyngioma | 1 | 2023 | 33 | 0.220 |
Why?
|
| Spinal Cord Compression | 2 | 2022 | 30 | 0.210 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1895 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 558 | 0.210 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2004 | 141 | 0.210 |
Why?
|
| Membrane Proteins | 3 | 2023 | 1525 | 0.210 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2023 | 25 | 0.210 |
Why?
|
| Biomarkers, Tumor | 3 | 2023 | 1491 | 0.210 |
Why?
|
| Humans | 41 | 2024 | 125014 | 0.210 |
Why?
|
| Muscular Dystrophies | 1 | 2023 | 52 | 0.210 |
Why?
|
| Membrane Glycoproteins | 2 | 2024 | 411 | 0.210 |
Why?
|
| Pituitary Neoplasms | 1 | 2023 | 80 | 0.200 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 35 | 0.200 |
Why?
|
| Calbindin 1 | 2 | 2017 | 3 | 0.200 |
Why?
|
| Antigens, CD | 1 | 2024 | 432 | 0.200 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2020 | 68 | 0.200 |
Why?
|
| Mice | 16 | 2024 | 17625 | 0.200 |
Why?
|
| Nervous System Malformations | 1 | 2024 | 130 | 0.200 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 133 | 0.200 |
Why?
|
| Biopsy | 5 | 2021 | 1235 | 0.190 |
Why?
|
| Gait Ataxia | 1 | 2021 | 5 | 0.190 |
Why?
|
| SOX9 Transcription Factor | 1 | 2022 | 80 | 0.190 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 9 | 0.190 |
Why?
|
| Phaeohyphomycosis | 1 | 2021 | 10 | 0.190 |
Why?
|
| Diplopia | 1 | 2021 | 39 | 0.180 |
Why?
|
| Disease Progression | 2 | 2024 | 2061 | 0.180 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 276 | 0.180 |
Why?
|
| Radiosurgery | 2 | 2013 | 111 | 0.180 |
Why?
|
| Brain Abscess | 1 | 2021 | 50 | 0.180 |
Why?
|
| Seizures | 4 | 2023 | 870 | 0.180 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2020 | 9 | 0.180 |
Why?
|
| Animals | 20 | 2024 | 34210 | 0.170 |
Why?
|
| Glycine-tRNA Ligase | 1 | 2020 | 6 | 0.170 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2020 | 20 | 0.170 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 171 | 0.170 |
Why?
|
| Child | 12 | 2023 | 24339 | 0.170 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 22 | 0.170 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 75 | 0.170 |
Why?
|
| Proton Therapy | 1 | 2021 | 123 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 74 | 0.160 |
Why?
|
| Male | 22 | 2024 | 61429 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 293 | 0.160 |
Why?
|
| X-linked Nuclear Protein | 1 | 2019 | 17 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2019 | 188 | 0.160 |
Why?
|
| SMARCB1 Protein | 1 | 2018 | 37 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 67 | 0.150 |
Why?
|
| Rhabdoid Tumor | 1 | 2018 | 46 | 0.150 |
Why?
|
| Epithelioid Cells | 1 | 2018 | 11 | 0.150 |
Why?
|
| Mutation | 6 | 2024 | 5846 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 331 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 81 | 0.150 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2018 | 23 | 0.150 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2018 | 19 | 0.150 |
Why?
|
| Central Nervous System | 1 | 2019 | 255 | 0.150 |
Why?
|
| Child Behavior Disorders | 1 | 2018 | 66 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 101 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 62 | 0.140 |
Why?
|
| Spinal Cord Regeneration | 1 | 2016 | 4 | 0.140 |
Why?
|
| Papilledema | 1 | 2018 | 78 | 0.140 |
Why?
|
| Homozygote | 1 | 2019 | 547 | 0.130 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 236 | 0.130 |
Why?
|
| Heterozygote | 1 | 2019 | 671 | 0.130 |
Why?
|
| Female | 23 | 2022 | 66709 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 375 | 0.130 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 92 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 732 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2018 | 314 | 0.130 |
Why?
|
| Zika Virus Infection | 1 | 2018 | 171 | 0.120 |
Why?
|
| White Muscle Disease | 1 | 2015 | 5 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 1265 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2023 | 3741 | 0.120 |
Why?
|
| Neural Crest | 1 | 2015 | 55 | 0.120 |
Why?
|
| SOXE Transcription Factors | 1 | 2014 | 15 | 0.120 |
Why?
|
| Thoracic Vertebrae | 2 | 2013 | 68 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 618 | 0.110 |
Why?
|
| Hamartoma | 1 | 2015 | 52 | 0.110 |
Why?
|
| Germinoma | 1 | 2014 | 30 | 0.110 |
Why?
|
| Infant | 9 | 2024 | 12458 | 0.110 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2017 | 221 | 0.110 |
Why?
|
| Encephalitis | 1 | 2015 | 111 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 2397 | 0.110 |
Why?
|
| Skull | 1 | 2015 | 141 | 0.110 |
Why?
|
| Gyrus Cinguli | 2 | 2005 | 116 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2020 | 8194 | 0.110 |
Why?
|
| Infant, Premature | 1 | 2019 | 817 | 0.110 |
Why?
|
| Spina Bifida Cystica | 1 | 2013 | 35 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 313 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2017 | 553 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1892 | 0.100 |
Why?
|
| Synapses | 1 | 2017 | 454 | 0.100 |
Why?
|
| Diagnosis, Differential | 4 | 2024 | 1888 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 454 | 0.100 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2013 | 30 | 0.100 |
Why?
|
| Spinal Cord | 3 | 2022 | 303 | 0.100 |
Why?
|
| SOXF Transcription Factors | 1 | 2012 | 18 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 302 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3156 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 78 | 0.100 |
Why?
|
| Adult | 9 | 2021 | 29620 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2019 | 1501 | 0.100 |
Why?
|
| Hippocampus | 1 | 2017 | 824 | 0.100 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2011 | 7 | 0.090 |
Why?
|
| Arteriovenous Malformations | 1 | 2011 | 47 | 0.090 |
Why?
|
| Young Adult | 5 | 2021 | 9045 | 0.090 |
Why?
|
| Ameloblasts | 1 | 2010 | 5 | 0.090 |
Why?
|
| Dental Enamel | 1 | 2010 | 17 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 423 | 0.090 |
Why?
|
| Meningomyelocele | 1 | 2013 | 250 | 0.090 |
Why?
|
| Mesoderm | 1 | 2010 | 110 | 0.080 |
Why?
|
| Twins, Dizygotic | 1 | 2010 | 42 | 0.080 |
Why?
|
| Cerebral Ventricles | 1 | 2010 | 81 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2010 | 81 | 0.080 |
Why?
|
| Epithelium | 1 | 2010 | 363 | 0.080 |
Why?
|
| Patient Care Planning | 1 | 2010 | 122 | 0.080 |
Why?
|
| Atrophy | 1 | 2010 | 230 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 647 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2010 | 356 | 0.080 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2009 | 57 | 0.080 |
Why?
|
| Equipment Contamination | 1 | 2009 | 37 | 0.080 |
Why?
|
| Rats | 3 | 2022 | 3717 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2019 | 1694 | 0.080 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 259 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2020 | 168 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 618 | 0.070 |
Why?
|
| Age Factors | 2 | 2015 | 2816 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1698 | 0.070 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2012 | 399 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 4390 | 0.070 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 329 | 0.070 |
Why?
|
| Pregnancy | 3 | 2019 | 7192 | 0.070 |
Why?
|
| Adolescent | 5 | 2022 | 19320 | 0.060 |
Why?
|
| Chick Embryo | 2 | 2017 | 131 | 0.060 |
Why?
|
| Gestational Age | 1 | 2010 | 1160 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 45 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2018 | 794 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 1241 | 0.060 |
Why?
|
| Calbindins | 1 | 2004 | 17 | 0.060 |
Why?
|
| Calbindin 2 | 1 | 2004 | 18 | 0.060 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2004 | 25 | 0.060 |
Why?
|
| Nicotine | 1 | 2005 | 143 | 0.060 |
Why?
|
| Parvalbumins | 1 | 2004 | 35 | 0.060 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2004 | 27 | 0.060 |
Why?
|
| Transfection | 2 | 2018 | 1068 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2020 | 13978 | 0.060 |
Why?
|
| Embryo, Mammalian | 2 | 2018 | 460 | 0.060 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2024 | 26 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2024 | 144 | 0.050 |
Why?
|
| Cell Count | 1 | 2004 | 254 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 389 | 0.050 |
Why?
|
| Mevalonic Acid | 1 | 2023 | 19 | 0.050 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2023 | 27 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 1006 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2023 | 92 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2022 | 50 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 779 | 0.050 |
Why?
|
| Spasm | 1 | 2022 | 49 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 397 | 0.050 |
Why?
|
| Head | 1 | 2022 | 103 | 0.050 |
Why?
|
| Potassium | 1 | 2023 | 282 | 0.050 |
Why?
|
| Ascomycota | 1 | 2021 | 24 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2023 | 281 | 0.050 |
Why?
|
| Fourth Ventricle | 1 | 2021 | 10 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2022 | 211 | 0.050 |
Why?
|
| Asthma | 1 | 2009 | 755 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 2100 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 1113 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2013 | 3070 | 0.040 |
Why?
|
| Base Sequence | 2 | 2017 | 3102 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 760 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 341 | 0.040 |
Why?
|
| Middle Aged | 5 | 2013 | 26918 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 161 | 0.040 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2020 | 44 | 0.040 |
Why?
|
| Glypicans | 1 | 2020 | 35 | 0.040 |
Why?
|
| Thrombospondins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Remyelination | 1 | 2019 | 7 | 0.040 |
Why?
|
| Phenotype | 2 | 2020 | 4259 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2022 | 339 | 0.040 |
Why?
|
| Embolization, Therapeutic | 2 | 2013 | 219 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2020 | 122 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 4531 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 22 | 0.040 |
Why?
|
| Emulsions | 1 | 2019 | 69 | 0.040 |
Why?
|
| Soybean Oil | 1 | 2019 | 70 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 1285 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 69 | 0.040 |
Why?
|
| Fish Oils | 1 | 2019 | 84 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 142 | 0.040 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2020 | 199 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 1999 | 175 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 2018 | 22 | 0.040 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2018 | 16 | 0.040 |
Why?
|
| Histones | 1 | 2022 | 523 | 0.040 |
Why?
|
| Subarachnoid Space | 1 | 2018 | 24 | 0.040 |
Why?
|
| Acetazolamide | 1 | 2018 | 30 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2018 | 35 | 0.040 |
Why?
|
| Colombia | 1 | 2018 | 48 | 0.040 |
Why?
|
| Spinal Puncture | 1 | 2018 | 51 | 0.040 |
Why?
|
| Dopamine | 1 | 1999 | 283 | 0.040 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2018 | 24 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 881 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 60 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 1999 | 184 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2018 | 79 | 0.040 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 53 | 0.040 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 41 | 0.040 |
Why?
|
| Serum | 1 | 2018 | 46 | 0.040 |
Why?
|
| Etoposide | 1 | 2018 | 115 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 93 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 105 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3345 | 0.040 |
Why?
|
| Karyotyping | 1 | 2018 | 323 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2019 | 231 | 0.040 |
Why?
|
| Craniotomy | 1 | 2018 | 109 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2022 | 864 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 1999 | 351 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2017 | 26 | 0.030 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2016 | 16 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 335 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2017 | 40 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 172 | 0.030 |
Why?
|
| Schizophrenia | 1 | 1999 | 311 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 226 | 0.030 |
Why?
|
| Pyridines | 1 | 2018 | 230 | 0.030 |
Why?
|
| Triglycerides | 1 | 2019 | 575 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 521 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 488 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1062 | 0.030 |
Why?
|
| Piperazines | 1 | 2018 | 239 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 4403 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 277 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 812 | 0.030 |
Why?
|
| Swine | 1 | 2019 | 1207 | 0.030 |
Why?
|
| Lysophosphatidylcholines | 1 | 2015 | 13 | 0.030 |
Why?
|
| Parietal Bone | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 618 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2020 | 875 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2018 | 242 | 0.030 |
Why?
|
| Occipital Bone | 1 | 2015 | 20 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Aging | 2 | 2016 | 1184 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 156 | 0.030 |
Why?
|
| Microcephaly | 1 | 2018 | 331 | 0.030 |
Why?
|
| Photomicrography | 1 | 2014 | 12 | 0.030 |
Why?
|
| Electroporation | 1 | 2014 | 32 | 0.030 |
Why?
|
| Myelin Basic Protein | 1 | 2014 | 68 | 0.030 |
Why?
|
| Pineal Gland | 1 | 2014 | 18 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2015 | 194 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 940 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 238 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1632 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1328 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 190 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 203 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 86 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 540 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 979 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1757 | 0.030 |
Why?
|
| Hypoxia | 1 | 2015 | 248 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2013 | 111 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16307 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2013 | 12383 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2013 | 135 | 0.020 |
Why?
|
| GATA4 Transcription Factor | 1 | 2012 | 35 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 372 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2012 | 76 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 98 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2012 | 98 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 388 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2013 | 187 | 0.020 |
Why?
|
| Stroke | 1 | 2019 | 986 | 0.020 |
Why?
|
| Diaphragm | 1 | 2012 | 98 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2821 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 445 | 0.020 |
Why?
|
| Meningioma | 1 | 2013 | 120 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2011 | 52 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 452 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 549 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1016 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 258 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1504 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 951 | 0.020 |
Why?
|
| Stem Cells | 1 | 2015 | 706 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 794 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2013 | 597 | 0.020 |
Why?
|
| Cladosporium | 1 | 2009 | 1 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 191 | 0.020 |
Why?
|
| Budesonide | 1 | 2009 | 19 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3051 | 0.020 |
Why?
|
| Fungi | 1 | 2009 | 69 | 0.020 |
Why?
|
| Candida | 1 | 2009 | 75 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4811 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 862 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1933 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6326 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5168 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 130 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2005 | 47 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 258 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 457 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 348 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 684 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3454 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 2906 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6595 | 0.010 |
Why?
|
| Haloperidol | 1 | 1999 | 23 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1999 | 54 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1999 | 34 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 19854 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1999 | 87 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 1999 | 44 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1999 | 110 | 0.010 |
Why?
|
| Axons | 1 | 1999 | 370 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 10282 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1999 | 1024 | 0.010 |
Why?
|